Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
methoxamine alpha-1a adrenergic receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Hypotension[MeSHID:D007022]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Hypertensive disease[MeSHID:D006973]		 1.77 approved,investigational agonist
methoxamine alpha-1b adrenergic receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Hypotension[MeSHID:D007022]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Hypertensive disease[MeSHID:D006973]		 2.72 approved,investigational agonist
methoxamine adrenergic receptor alpha-1b NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Hypotension[MeSHID:D007022]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Hypertensive disease[MeSHID:D006973]		 2.72 approved agonist
methoxamine adrenergic receptor alpha-1b NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Hypotension[MeSHID:D007022]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Hypertensive disease[MeSHID:D006973]		 2.72 approved unknown
methoxamine alpha-1d adrenergic receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Hypotension[MeSHID:D007022]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Hypertensive disease[MeSHID:D006973]		 1.35 approved,investigational binder,agonist
methoxamine alpha-1d adrenergic receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Hypotension[MeSHID:D007022]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Hypertensive disease[MeSHID:D006973]		 1.35 approved,investigational binder
click here to return to the previous page